IP Library Granted Patent US 9,441,203
Granted Patent B2
US 9,441,203 · App. 14/231,221 · Granted Sep 13, 2016

Medium for the protein-free and serum-free cultivation of cells

Inventors: Manfred Reiter (Vienna, AT); Wolfgang Mundt (Vienna, AT); Friedrich Dorner (Vienna, AT); Leopold Grillberger (Vienna, AT); Artur Mitterer (Orth/Donau, AT)
Assignee: Baxalta Innovations GmbH
C12N5/0682C12N5/0043C12N2500/32C12N2500/60C12N2500/76C12N2500/92
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,441,203
App. No.
14/231,221
Granted
Sep 13, 2016
Kind
B2
Abstract

A medium is described for the protein-free and serum-free cultivation of cells, especially mammalian cells, whereby the medium contains a proportion of soy hydrolysate.

Claims (18)

1. A method of adapting recombinant cells to serum-free and animal protein-free medium, the method comprising:

a. culturing recombinant cells in serum-containing medium,

b. transferring said cells into a serum-free and animal protein-free medium, wherein the medium comprises soy hydrolysate wherein at least 40% of said soy hydrolysate has a molecular weight of ≦500 Daltons, and

c. culturing said cells in said serum-free and animal protein-free medium;

wherein the serum-free and animal protein-free medium contains a quantity in excess of 10 wt % soy hydrolysate based on the total dry weight of the medium.

2. The method of claim 1 , wherein said medium contains ultrafiltered soy hydrolysate.

3. The method of claim 2 , wherein the medium contains ultrafiltered soy hydrolysate.

4. The method of claim 1 , wherein the soy hydrolysate has an endotoxin content of <500 U/g.

5. The method of claim 1 , wherein at least 50% of the soy hydrolysate has a molecular weight of ≦500 Daltons.

6. The method of claim 5 , wherein at least 55% of the soy hydrolysate has a molecular weight of ≦500 Daltons.

7. The method of claim 1 , wherein the medium also contains an amino acid.

8. The method of claim 6 , wherein the amino acid is selected from the group consisting of L-asparagine, L-cysteine, L-cystine, L-proline, L-tryptophan, and L-glutamine, or mixtures thereof.

9. The method of claim 1 , wherein the medium also contains one or more auxiliary substances selected from the group consisting of buffer substances, oxidation stabilizers, stabilizers to counteract mechanical stress, and protease inhibitors.

10. The method of claim 1 , wherein the cells contain a coding sequence for a recombinant blood factor, and are capable of expressing the recombinant blood factor.

11. The method of claim 10 , wherein the recombinant blood factor is Factor II, Factor V, Factor VII, Factor VIII, Factor IX, Factor X, Factor XI, Protein S, Protein C, or vWF, or an activated form of the recombinant blood factor.

12. The method of claim 11 , wherein the cells contain a coding sequence for Factor VIII.

13. The method of claim 1 , wherein the cells are CHO or BHK cells.

14. The method of claim 1 , wherein the cells are CHO cells that express Factor VIII or a protein with Factor VIII activity.

Assignments (8)
CHANGE OF NAME Recorded Apr 20, 2017
From: BAXTER AKTIENGESELLSCHAFT
To: BAXTER EASTERN EUROPE VERTRIEBS GMBH
Reel/Frame 042297/0975 →
CHANGE OF NAME Recorded Apr 20, 2017
From: BAXTER EASTERN EUROPE VERTRIEBS GMBH
To: BAXTER TRADING GMBH
Reel/Frame 042301/0300 →
CHANGE OF NAME Recorded Apr 20, 2017
From: BAXTER TRADING GMBH
To: BAXTER INNOVATIONS GMBH
Reel/Frame 042301/0490 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2017
From: BAXALTA INNOVATIONS GMBH
To: BAXALTA INCORPORATED; BAXALTA GMBH
Reel/Frame 042084/0971 →
CHANGE OF NAME Recorded Feb 9, 2016
From: BAXTER AKTIENGESELLSCHAFT
To: BAXTER INNOVATIONS GMBH
Reel/Frame 037759/0053 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2016
From: REITER, MANFRED; MUNDT, WOLFGANG; DORNER, FRIEDRICH; GRILLBERGER, LEOPOLD; MITTERER, ARTUR
To: BAXTER AKTIENGESELLSCHAFT
Reel/Frame 037692/0202 →
CHANGE OF NAME Recorded Feb 1, 2016
From: BAXTER INNOVATIONS GMBH
To: BAXALTA INNOVATIONS GMBH
Reel/Frame 037677/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 25, 2014
From: REITER, MANFRED; MUNDT, WOLFGANG; DORNER, FRIEDRICH; GRILLBERGER, LEOPOLD; MITTERER, ARTUR
To: BAXTER INNOVATIONS GMBH
Reel/Frame 034259/0782 →
Priority Claims (1)
AT A 1659/99 · Sep 28, 1999 · national
Continuity (5)
Continuation 13198476 · Aug 4, 2011
Continuation 11841915 · Aug 20, 2007
Continuation 10405794 · Apr 1, 2003
Continuation 09672240 · Sep 28, 2000
Related Publication 20150072415A1 · Mar 12, 2015